Human papillomavirus and cervical cancer M Schiffman, PE Castle, J Jeronimo, AC Rodriguez, S Wacholder The lancet 370 (9590), 890-907, 2007 | 3862 | 2007 |
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early … D Saslow, D Solomon, HW Lawson, M Killackey, SL Kulasingam, J Cain, ... American journal of clinical pathology 137 (4), 516-542, 2012 | 3188 | 2012 |
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in … MJ Khan, PE Castle, AT Lorincz, S Wacholder, M Sherman, DR Scott, ... Journal of the National cancer Institute 97 (14), 1072-1079, 2005 | 1484 | 2005 |
The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists … TM Darragh, TJ Colgan, JT Cox, DS Heller, MR Henry, RD Luff, ... Archives of pathology & laboratory medicine 136 (10), 1266-1297, 2012 | 1197 | 2012 |
Human papillomavirus testing in the prevention of cervical cancer M Schiffman, N Wentzensen, S Wacholder, W Kinney, JC Gage, ... Journal of the National cancer institute 103 (5), 368-383, 2011 | 1028 | 2011 |
2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors RB Perkins, RS Guido, PE Castle, D Chelmow, MH Einstein, F Garcia, ... Journal of lower genital tract disease 24 (2), 102-131, 2020 | 927 | 2020 |
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older CJLM Meijer, J Berkhof, PE Castle, AT Hesselink, EL Franco, G Ronco, ... International journal of cancer 124 (3), 516-520, 2009 | 852 | 2009 |
Comprehensive control of human papillomavirus infections and related diseases FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ... Vaccine 31, H1-H31, 2013 | 795 | 2013 |
The carcinogenicity of human papillomavirus types reflects viral evolution M Schiffman, R Herrero, R DeSalle, A Hildesheim, S Wacholder, ... Virology 337 (1), 76-84, 2005 | 770 | 2005 |
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors D Saslow, PE Castle, JT Cox, DD Davey, MH Einstein, DG Ferris, ... CA: a cancer journal for clinicians 57 (1), 7-28, 2007 | 744 | 2007 |
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice HA Katki, WK Kinney, B Fetterman, T Lorey, NE Poitras, L Cheung, ... The lancet oncology 12 (7), 663-672, 2011 | 700 | 2011 |
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections AC Rodríguez, M Schiffman, R Herrero, S Wacholder, A Hildesheim, ... Journal of the National Cancer Institute 100 (7), 513-517, 2008 | 686 | 2008 |
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of … PE Castle, MH Stoler, TC Wright, A Sharma, TL Wright, CM Behrens The lancet oncology 12 (9), 880-890, 2011 | 658 | 2011 |
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis ME Sherman, AT Lorincz, DR Scott, S Wacholder, PE Castle, AG Glass, ... Journal of the National Cancer Institute 95 (1), 46-52, 2003 | 650 | 2003 |
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica PE Castle, M Schiffman, R Herrero, A Hildesheim, AC Rodriguez, ... The Journal of infectious diseases 191 (11), 1808-1816, 2005 | 605 | 2005 |
Human papillomavirus: epidemiology and public health M Schiffman, PE Castle Archives of pathology & laboratory medicine 127 (8), 930-934, 2003 | 590 | 2003 |
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade … M Schiffman, PE Castle, D Maucort-Boulch, CM Wheeler, ... The Journal of infectious diseases 195 (11), 1582-1589, 2007 | 561 | 2007 |
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica R Herrero, PE Castle, M Schiffman, MC Bratti, A Hildesheim, J Morales, ... The Journal of infectious diseases 191 (11), 1796-1807, 2005 | 554 | 2005 |
Evidence for frequent regression of cervical intraepithelial neoplasia–grade 2 PE Castle, M Schiffman, CM Wheeler, D Solomon Obstetrics & Gynecology 113 (1), 18-25, 2009 | 547 | 2009 |
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses M Arbyn, SB Smith, S Temin, F Sultana, P Castle Bmj 363, 2018 | 537 | 2018 |